PP population included participants who completed NAC-treatment at full dosage (2 exclusions) beyond day 7 (8 exclusions), therefore considered exempt from major protocol deviation (PP: n = 13 in NAC- and 12 in placebo-group
Tesamorelin/Ipamorelin 8MG/2MG is a research material intended for laboratory and analytical investigation
doi: 10.1038/srep26236 (2016)
Contact your healthcare provider promptly if you experience any of the following after injection: significant swelling or hardness at the injection site that does not resolve within 48 hours, redness that expands beyond two inches from the injection point, warmth or heat radiating from the injection site combined with pain, any discharge from the injection site including pus or cloudy fluid, fever following injection, severe allergic reaction signs including hives or difficulty breathing, or persistent pain that intensifies rather than improving over 24 hours
The company is also planning to launch a pen device, likely in April, priced at 4,000 4,500 monthly